Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
GoutArthritis, GoutyHyperuricemiaGout Chronic
Interventions
DRUG

AR882 50 mg

Solid Oral Capsule

DRUG

AR882 75 mg

Solid Oral Capsule

DRUG

Placebo

Matching Solid Oral Capsule Placebo

Trial Locations (68)

112

Arthrosi Investigative Site (403), Taipei

333

Arthrosi Investigative Site (401), Taoyuan

402

Arthrosi Investigative Site (402), Taichung

813

Arthrosi Investigative Site (406), Kaohsiung City

833

Arthrosi Investigative Site (404), Kaohsiung City

1010

Arthrosi Investigative Site (300), Auckland

2019

Arthrosi Investigative Site (202), Botany

3010

Arthrosi Investigative Site (301), Rotorua

3124

Arthrosi Investigative Site (200), Camberwell

3200

Arthrosi Investigative Site (304), Hamilton

7011

Arthrosi Investigative Site (303), Nelson

11215

Arthrosi Investigative Site (158), Brooklyn

11217

Arthrosi Investigative Site (400), Taipei

19040

Arthrosi Investigative Site (120), Hatboro

21740

Arthrosi Investigative Site (150), Hagerstown

22601

Arthrosi Investigative Site (134), Winchester

23666

Arthrosi Investigative Site (111), Hampton

Arthrosi Investigative Site (118), Hampton

27410

Arthrosi Investigative Site (137), Greensboro

28150

Arthrosi Investigative Site (140), Shelby

28277

Arthrosi Investigative Site (161), Valencia

28403

Arthrosi Investigative Site (130), Wilmington

29572

Arthrosi Investigative Site (147), Myrtle Beach

30047

Arthrosi Investigative Site (162), Lilburn

30329

Arthrosi Investigative Site (164), Atlanta

32720

Arthrosi Investigative Site (128), DeLand

32751

Arthrosi Investigative Site (156), Maitland

33024

Arthrosi Investigative Site (102), Hollywood

33134

Arthrosi Investigative Site (115), Coral Gables

33176

Arthrosi Investigative Site (103), Miami

33756

Arthrosi Investigative Site (149), Clearwater

33880

Arthrosi Investigative Site (151), Winter Haven

36535

Arthrosi Investigative Site (106), Foley

44195

Arthrosi Investigative Site (148), Cleveland

45429

Arthrosi Investigative Site (146), Dayton

48076

Arthrosi Investigative Site (105), Detroit

48109

Arthrosi Investigative Site (122), River Forest

Arthrosi Investigative Site (121), Ann Arbor

57702

Arthrosi Investigative Site (132), Rapid City

64151

Arthrosi Investigative Site (119), Kansas City

67207

Arthrosi Investigative Site (154), Wichita

70115

Arthrosi Investigative Site (144), New Orleans

75024

Arthrosi Investigative Site (129), Plano

75251

Arthrosi Investigative Site (104), Dallas

76450

Arthrosi Investigative Site (116), Graham

77375

Arthrosi Investigative Site (107), Tomball

77377

Arthrosi Investigative Site (124), Tomball

77459

Arthrosi Investigative Site (136), Missouri City

77566

Arthrosi Investigative Site (126), Lake Jackson

78681

Arthrosi Investigative Site (127), Round Rock

79106

Arthrosi Investigative Site (110), Amarillo

80014

Arthrosi Investigative Site (101), Aurora

83713

Arthrosi Investigative Site (133), Boise

84405

Arthrosi Investigative Site (145), Ogden

85037

Arthrosi Investigative Site (112), Phoenix

85281

Arthrosi Investigative Site (114), Tempe

85381

Arthrosi Investigative Site (160), Peoria

91355

Arthrosi Investigative Site (157), Palmetto Bay

91730

Arthrosi Investigative Site (138), Rancho Cucamonga

92024

Arthrosi Investigative Site (117), Encinitas

92108

Arthrosi Investigative Site (131), El Cajon

97002

Arthrosi Investigative Site (405), Hualien City

98021

Arthrosi Investigative Site (142), Bountiful

99508

Arthrosi Investigative Site (139), Anchorage

38654-3514

Arthrosi Investigative Site (153), Olive Branch

Unknown

Arthrosi Investigative Site (500), Hong Kong

Arthrosi Investigative Site (501), Hong Kong

0632

Arthrosi Investigative Site (302), Auckland

Sponsors
All Listed Sponsors
lead

Arthrosi Therapeutics

INDUSTRY

NCT06439602 - Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) | Biotech Hunter | Biotech Hunter